Skip to content

Author

Y. Hoshino

We have 3 of 47 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Treatment-associated factors potentially linked to relapse in pediatric MOG antibody-associated disease: An exploratory case series.

BACKGROUND Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory demyelination disorder primarily affecting children. Pediatric-onset MOGAD typically responds well to corticosteroids; however, predictors of relapse and optimal strategies for sustained remission remain unclear. OBJ...

Shimpei Matsuda, S. Shimada, Takato Akiba et al. · 0 citations
Aug 2026

Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Optic Neuritis With Perineuritis Treated With Immunoadsorption Plasmapheresis in a 91‐Year‐Old Woman: A Case Report

Myelin oligodendrocyte glycoprotein antibody‐associated disease can occur in older adults, but onset in nonagenarians is uncommon. In this age group, acute or subacute visual loss often requires differentiation from ischemic, diabetic retinal, and glaucomatous disorders. A 91‐year‐old woman presented with...

Isamu Takai, Yuji Tomizawa, Y. Hoshino et al. · 0 citations
Open access 2026

Associating a Polygenic Risk Score for Multiple Sclerosis with Brain MRI Metrics and Cognitive Performance in Healthy UK Biobank Participants.

In neurologically healthy individuals, a higher genetic burden for MS was associated with slower information processing speed in the highest-risk subgroup and with altered WM microstructure in the splenium of the corpus callosum.

Chen-Yue Feng, J. Kikuta, A. Hagiwara et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.